Manzoor Ur Rahman Mir

Manzoor Ur Rahman Mir

Auto-generated profile, based on publicly available information

Manzoor Ur Rahman Mir

Molecular Biology Laboratory, Division of Veterinary Biochemistry, Faculty of Veterinary Sciences & Animal Husbandry, SKUAST-K, Srinagar, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
BABilal Ahmad
Bilal Ahmad
MRMuneeb U Rehman
Muneeb U Rehman
IAInsha Amin
Insha Amin
AAAhmad Arif
Ahmad Arif
SRSaiema Rasool
Saiema Rasool
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
Humans have been using natural products for medicinal use for ages. Natural products of therapeutic importance are compounds derived from plants, animals, or any microorganism. Ginger is also one of the most commonly used condiments and a natural drug in vogue. It is a traditional medicine, having some active ingredients used for the treatment of numerous diseases. During recent research on ginger, various ingredients like zingerone, shogaol, and paradol have been obtained from it. Zingerone (4‐(4‐hydroxy‐3‐methoxyphenyl)‐2‐butanone) is a nontoxic and inexpensive compound with varied pharmacological activities. It is the least pungent component of Zingiber officinale. Zingerone is absent in fresh ginger but cooking or heating transforms gingerol to zingerone. Zingerone closely related to vanillin from vanilla and eugenol from clove. Zingerone has potent anti‐inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic, and so forth properties. Besides, it displays the property of enhancing growth and immune stimulation. It behaves as appetite stimulant, anxiolytic, antithrombotic, radiation protective, and antimicrobial. Also, it inhibits the reactive nitrogen species which are important in causing Alzheimer’s disease and many other disorders. This review is written to shed light on the various pharmacological properties of zingerone and its role in alleviating numerous human and animal diseases.

9 June 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
IAInsha Amin
Insha Amin
IHIshraq Hussain
Ishraq Hussain
MRMuneeb U Rehman
Muneeb U Rehman
BMBilal Ahmad Mir
Bilal Ahmad Mir
SGShowkat Ahmad Ganaie
Showkat Ahmad Ganaie
Parvaiz AhmadParvaiz Ahmad
Parvaiz Ahmad

1 December 2018 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
BABilal Ahmad
Bilal Ahmad
MRMuneeb U. Rehman
Muneeb U. Rehman
IAInsha Amin
Insha Amin
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
SASheikh B Ahmad
Sheikh B Ahmad
BFBilques Fatima
Bilques Fatima
Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes.

18 January 2018 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
MRMuneeb U Rehman
Muneeb U Rehman
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
AFAdil Farooq
Adil Farooq
SRShahzada Rashid
Shahzada Rashid
BABilal Ahmad
Bilal Ahmad
MGMajid Ahmad Ganaie
Majid Ahmad Ganaie

1 January 2017 in Pharmacognosy Magazine
Verified
Journal Article
Open access
PDF file
NTNahida Tabassum
Nahida Tabassum
SSSheeba Shakeel
Sheeba Shakeel
MRMuneeb U Rehman
Muneeb U Rehman
UAUmar Amin
Umar Amin
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
Background: Epilepsy is a disorder of the central nervous system characterized by recurrent seizures. It is a very common disease in which approximately 30% of patients do not respond favourably to treatment with anticonvulsants. Oxidative stress is associated with neuronal damage arising from epileptic seizures. The present study investigated the effects of naringenin in pilocarpine-induced epilepsy in mice. Naringenin, one of the most frequently occurring flavanone in citrus fruits, was evaluated for its shielding effect against the pilocarpine induced behavioural, oxidative and histopathological alterations in rodent model of epilepsy. Methodology: Epilepsy was induced by giving pilocarpine (300mg/kg) and sodium valproate (300mg/kg) was given as standard anti-epileptic drug Pilocarpine was administered (300 mg /kg body weight) intraperitoneally to the mice on 15th day while naringenin was administered orally (20 and 40 mg/kg body weight) for 15 days prior to administration of pilocarpine. Results: The intraperitoneal administration of pilocarpine enhanced lipid peroxidation, caused reduction in antioxidant enzymes, viz., catalase, superoxide dismutase and glutathione reductase. Treatment of mice orally with naringenin (20 mg/kg body weight and 40 mg/kg body weight) resulted in a significant decrease in lipid peroxidation. There was significant recovery of glutathione content and all the antioxidant enzymes studied. Also in case of behavioural parameters studied, naringenin showed decrease in seizure severity. All these changes were supported by histological observations, which revealed excellent improvement in neuronal damage. Conclusion: The higher dose of naringenin was more potent in our study and was comparable to the standard drug (sodium valproate) in effectiveness. Abbreviations used:6-OHDA: 6-hydroxydopamine, AED: Anti epileptic drugs, AIDS: Acquired immune deficiency syndrome, ANOVA: Analysis of variance, ATP: Adenosine triphosphate, CA: Cornu ammonis, CAT: Catalase, DG: Dentate gyrus, EDTA: Ethylenediamine tetra acetic acid, GR: Glutathione reductase, GSH: Glutathione reduced, HCl: Hydrochloric acid, IL-1β: Interleukin 1 beta, LPO: Lipid peroxidation, MDA: Malondialdehyde, NADPH: Nicotinamide adenine dinucleotide phosphate, PMS: post mitochondrial supernatant, SE: Status epilepticus, SEM: Standard error of the mean, SOD Superoxide dismutase, TBA: Thiobarbituric acid, TBARS: Thiobarbituric acid reactive substance, TLE: Temporal lobe epilepsy, TNF-α: Tumor necrosis factor alpha

18 December 2017 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
SASheikh B Ahmad
Sheikh B Ahmad
MRMuneeb U. Rehman
Muneeb U. Rehman
BFBilques Fatima
Bilques Fatima
BABilal Ahmad
Bilal Ahmad
IHIshraq Hussain
Ishraq Hussain
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir